Since the launch of Arizona’s Bioscience Roadmap in 2002, the Flinn Foundation has commissioned Battelle (now TEConomy Partners) to track progress on performance measures involving the state’s bioscience sector. Data pertaining to a consistent set of metrics was gathered and reported publicly on an annual basis during the Roadmap’s first decade, and is issued biennially during the second decade.

A Roadmap progress update by TEConomy Partners in March 2016 revealed the following data—the most recent available—on key metrics.

Jobs: During the economic recovery of 2009-2014, bioscience jobs in Arizona increased 14.8%, nearly double the rate of Arizona as a whole. From 2002 to 2014, Arizona bioscience jobs increased by 49%, adding more than 36,700 jobs for a total of 110,410. The U.S. posted a 13.7% gain in bio jobs during this span.

Wages: Bioscience workers in Arizona earn an average annual salary of $61,823, compared to $46,514 for the state’s private sector as a whole. From 2002 to 2014, bio salaries increased 50%.

Firms: From 2002 to 2014, the number of Arizona bioscience establishments rose 4.2%, to 1,411. The cited growth rate was much higher before the biosciences were reclassified in 2014 to include bio-distribution firms.

NIH Grants: In 2015, while total NIH funding rose, Arizona’s funding fell to $151 million from $158 million in 2014. From 2002 to 2015, Arizona’s NIH funding grew 11.8%, far behind the top-10 funded states’ growth of 40.1%. Through most of the Roadmap’s history, Arizona had kept pace with these states.

R&D Expenditures: The value of bioscience-related academic research-and-development expenditures at Arizona’s universities reached $451 million in 2014, a slight drop from 2013. Since 2002, Arizona’s R&D expenditures are up 55.1%, versus the overall U.S. growth of 77.5%.

Venture Capital: In 2015, bioscience firms in Arizona attracted $82 million in venture-capital investments, the highest level since 2011, and the third straight year of growth. This was, though, just 0.56% of bioscience VC investments nationwide.

University Tech Transfer: From 2002 to 2015, Arizona’s universities have shown steady gains in developing bioscience intellectual property: invention disclosures, patent applications, patents issued, and licenses and options executed. The 2014-15 period compared favorably to the previous two years on all measures, including a 24% increase in bio-related university startups.


Data is tracked on the six industry subsectors that comprise Arizona’s definition of the biosciences. It should be noted that the industry data reflect only private industry; research-related jobs at state universities and private research institutions are not incorporated. Also, Arizona’s definition of the biosciences shifted with the updated Roadmap in 2014 to reflect changes in the national definition by Battelle and the Biotechnology Industry Organization. Thus, these industry data do not correlate directly to those from the first decade. Details are available in Arizona’s Bioscience Roadmap, 2014-2025.

Data from earlier years is available on the First Decade page.

For additional data released in 2016, visit Presentation: 2014-15 Data on Arizona’s Bioscience Sector